The use of drugs in the management of strabismus.
D000550:Amblyopia / Q000188:drug therapy; D000577:Amides / Q000627:therapeutic use; D001285:Atropine / Q000627:therapeutic use; D001463:Barbiturates / Q000627:therapeutic use; D001919:Bradycardia / Q000139:chemically induced; D002386:Cataract / Q000139:chemically induced; D002490:Central Nervous System / Q000187:drug effects; D002697:Chloral Hydrate / Q000627:therapeutic use; D003560:Cysts / Q000139:chemically induced; D004456:Echothiophate Iodide / Q000627:therapeutic use; D005654:Fundus Oculi; D006801:Humans; D007498:Iris / Q000187:drug effects; D007531:Isoflurophate / Q000627:therapeutic use; D008916:Miotics / Q000009:adverse effects / Q000627:therapeutic use*; D009184:Mydriatics / Q000009:adverse effects / Q000627:therapeutic use*; D009596:Nitrophenols / Q000627:therapeutic use; D009801:Oculomotor Muscles / Q000187:drug effects; D010756:Phosphoric Acids / Q000627:therapeutic use; D010830:Physostigmine / Q000627:therapeutic use; D010862:Pilocarpine / Q000627:therapeutic use; D011422:Propionates / Q000627:therapeutic use; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use; D012601:Scopolamine / Q000627:therapeutic use; D013285:Strabismus / Q000188:drug therapy* / Q000601:surgery; D014149:Tranquilizing Agents / Q000627:therapeutic use; D014326:Tropanes / Q000627:therapeutic use
D000577:Amides; D001463:Barbiturates; D008916:Miotics; D009184:Mydriatics; D009596:Nitrophenols; D010756:Phosphoric Acids; D011422:Propionates; D000644:Quaternary Ammonium Compounds; D014149:Tranquilizing Agents; D014326:Tropanes; D010862:Pilocarpine; D007531:Isoflurophate; D002697:Chloral Hydrate; D001285:Atropine; D010830:Physostigmine; D004456:Echothiophate Iodide; D012601:Scopolamine